(MedPage Today) — A growth factor-stimulating gene therapy did not improve outcomes with vascularized lymph node transfer (VLNT) for breast cancer-related lymphedema in a small randomized trial, that added to evidence of VLNT safety and efficacy…
Source link : https://www.medpagetoday.com/hematologyoncology/breastcancer/114841
Author :
Publish date : 2025-03-26 19:49:00
Copyright for syndicated content belongs to the linked Source.
